Alzamend neuro announces positive topline data from phase 1 first-in-human clinical trial for al001 treatment of dementia related to alzheimer's

Tampa, fla.--(business wire)---- $aemd #505b2--alzamend neuro announces positive topline data from phase 1 first-in-human clinical trial for al001 treatment of dementia related to alzheimer's
AEMD Ratings Summary
AEMD Quant Ranking